VR Logo

Jagsonpal Pharmaceuticals: Board to consider Interim Dividend


Jagsonpal Pharmaceuticals Ltd has informed BSE that Meeting of Board of Directors of the Company will be held on October 19 2021 inter alia to consider and approve:

1. The Standalone Un-Audited Financial Results of the Company for the quarter and half year ended September 30 2021;

2. The Limited Review Report on Un-Audited Financial Results of the company for the quarter and half year ended September 30 2021;

3. The declaration of Interim Dividend if any;

Click here to view PDF